search
Back to results

Treatment of Periodontitis in Obese Individuals (CLIMBEO)

Primary Purpose

Obese, Obesity, Morbid, Periodontitis

Status
Completed
Phase
Phase 4
Locations
Brazil
Study Type
Interventional
Intervention
One-stage full-mouth disinfection with chlorhexidine
Sponsored by
University of Taubate
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obese focused on measuring Obesity, Periodontitis, Therapeutics, Chlorhexidine

Eligibility Criteria

18 Years - 50 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Moderate to advanced generalized chronic periodontitis
  • Body mass index: > 18.5 kg/m2
  • Minimum of 12 natural teeth
  • Smokers, non-smokers or former-smokers

Exclusion Criteria:

  • Systemic diseases (diabetes, renal diseases, rheumatic diseases, osteoporosis and cardiovascular diseases)
  • Pregnant and lactating women
  • HIV/ AIDS
  • periodontal treatment in the last year (before baseline appointment)
  • Medication: Immunosuppressive drugs, antibiotics in the past three months (before baseline appointment) )
  • orthodontic appliance

Sites / Locations

  • University of Taubate

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm Type

Experimental

Experimental

Experimental

Experimental

Experimental

Arm Label

Normal weight full-mouth disinfection

Overweight full-mouth disinfection

Obesity I full-mouth disinfection

Obesity II full-mouth disinfection

Obesity III full-mouth disinfection

Arm Description

Normal weight (body mass index 18.5 - 24.9 kg/m2) individuals with chronic periodontitis Full-mouth manual scaling and root planing within 24 hours tongue cleaning with chlorhexidine gel 1% for 1 minute tonsils disinfection with chlorhexidine spray 0.2% rinsing with 15mL of 0.2% chlorhexidine solution for 30 seconds before and after dental scaling subgingival irrigation of all periodontal pockets with 1% chlorhexidine solution daily rinsing with 0.2% chlorhexidine solution (15mL/30 seconds/2 times a day

Overweight (body mass index 25.0 - 29.9 kg/m2) individuals with chronic periodontitis Full-mouth manual scaling and root planing within 24 hours tongue cleaning with chlorhexidine gel 1% for 1 minute tonsils disinfection with chlorhexidine spray 0.2% rinsing with 15mL of 0.2% chlorhexidine solution for 30 seconds before and after dental scaling subgingival irrigation of all periodontal pockets with with 1% chlorhexidine solution daily rinsing with 0.2% chlorhexidine solution (15mL/30 seconds/2 times a day

Obesity I (body mass index 30.0 - 34.9 kg/m2) individuals with chronic periodontitis Full-mouth manual scaling and root planing within 24 hours tongue cleaning with chlorhexidine gel 1% for 1 minute tonsils disinfection with chlorhexidine spray 0.2% rinsing with 15mL of 0.2% chlorhexidine solution for 30 seconds before and after dental scaling subgingival irrigation of all periodontal pockets with with 1% chlorhexidine solution daily rinsing with 0.2% chlorhexidine solution (15mL/30 seconds/2 times a day

Obesity II (body mass index 35.0 - 39.9 kg/m2) individuals with chronic periodontitis Full-mouth manual scaling and root planing within 24 hours tongue cleaning with chlorhexidine gel 1% for 1 minute tonsils disinfection with chlorhexidine spray 0.2% rinsing with 15mL of 0.2% chlorhexidine solution for 30 seconds before and after dental scaling subgingival irrigation of all periodontal pockets with with 1% chlorhexidine solution daily rinsing with 0.2% chlorhexidine solution (15mL/30 seconds/2 times a day

Obesity III (body mass index ≥ 40.0 kg/m2) individuals with chronic periodontitis Full-mouth manual scaling and root planing within 24 hours tongue cleaning with chlorhexidine gel 1% for 1 minute tonsils disinfection with chlorhexidine spray 0.2% rinsing with 15mL of 0.2% chlorhexidine solution for 30 seconds before and after dental scaling subgingival irrigation of all periodontal pockets with with 1% chlorhexidine solution daily rinsing with 0.2% chlorhexidine solution (15mL/30 seconds/2 times a day

Outcomes

Primary Outcome Measures

Periodontal clinical efficacy
Improvements in periodontal pocket depth (mm) overtime and comparisons among groups at 6 months after treatment
Periodontal clinical efficacy
Improvements in clinical attachment level (mm) overtime and comparisons among groups at 6 months after treatment

Secondary Outcome Measures

Antimicrobial efficacy
Reductions in total bacterial levels and levels of target bacterial species overtime and comparisons among groups at 6 months after treatment
Antimicrobial efficacy
Reductions in Treponema denticola, Porphyromonas gingivalis, Tannerella forsythia, Aggregatibacter actinomycetemcomitans levels overtime and comparisons among groups at 6 months after treatment
Oral safety and tolerability
Maintenance of salivary nitrite levels overtime and comparisons among groups at 6 months after treatment
Impact on quality of life
Improvements in Oral health and quality of life - United Kingdom questionnaire scores overtime and comparisons among groups at 6 months after treatment
Impact on quality of life
Improvements in Oral impacts on daily performance questionnaire scores overtime and comparisons among groups at 6 months after treatment

Full Information

First Posted
March 14, 2017
Last Updated
July 19, 2019
Sponsor
University of Taubate
search

1. Study Identification

Unique Protocol Identification Number
NCT03103204
Brief Title
Treatment of Periodontitis in Obese Individuals
Acronym
CLIMBEO
Official Title
Clinical, Microbial and Biochemistry Evaluation of Obese Individuals Submitted to One-stage Full-mouth Disinfection. A Clinical Control Parallel Study
Study Type
Interventional

2. Study Status

Record Verification Date
July 2019
Overall Recruitment Status
Completed
Study Start Date
January 21, 2017 (Actual)
Primary Completion Date
July 28, 2017 (Actual)
Study Completion Date
December 28, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Taubate

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Obesity and gum diseases are highly prevalent in all parts of the world. Obesity can negatively influence severity and progression rates of gum diseases. Presence of fat in the body determines a general systemic state of inflammation. On the other hand, when gum diseases are successfully treated systemic and local inflammation decrease. In addition reductions in glycemic blood levels are also observed after treatment. Periodontitis is one type of gum disease that is associated with bone loss. It could be treated within 24 hours by using a protocol, which combines dental debridement and mouthwash. This treatment protocol, named "one-stage full-mouth disinfection" works well in individuals of normal weight. However, there is no information whether it is effective in obese individuals or not. Also, it should be clarified if obesity influences response to periodontal treatment. This study hypothesized that obesity impair response to periodontal treatment. Therefore, the effects of the protocol "one-stage full-mouth disinfection" will be evaluated in obese individuals and normal weight controls. This evaluation will be based on the monitoring of several clinical, microbiological and biochemical parameters throughout 9 months. Participants will answer validated questionnaires to evaluate if treatment of gum disease would be able to improve individual's quality of life. Study population will be composed of 90 to 100 obese individuals (males or females; > 18 years of age; smokers or non smokers; > 12 natural teeth). Participants will be classified into 5 groups according to their body mass index in normal weight (n = 15 to 20); overweight (n = 15 to 20); obesity I (n = 15 to 20); obesity II (n = 15 to 20); obesity III (n = 15 to 20). Examinations will be performed before treatment and also 3, 6 and 9 months after treatment. This study will contribute to the knowledge on how obese individuals respond to this specific treatment protocol. Also, having normal weight individuals as controls the present study will contribute to a better understanding about obesity, in its different severities, influence on periodontal treatment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obese, Obesity, Morbid, Periodontitis
Keywords
Obesity, Periodontitis, Therapeutics, Chlorhexidine

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
96 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Normal weight full-mouth disinfection
Arm Type
Experimental
Arm Description
Normal weight (body mass index 18.5 - 24.9 kg/m2) individuals with chronic periodontitis Full-mouth manual scaling and root planing within 24 hours tongue cleaning with chlorhexidine gel 1% for 1 minute tonsils disinfection with chlorhexidine spray 0.2% rinsing with 15mL of 0.2% chlorhexidine solution for 30 seconds before and after dental scaling subgingival irrigation of all periodontal pockets with 1% chlorhexidine solution daily rinsing with 0.2% chlorhexidine solution (15mL/30 seconds/2 times a day
Arm Title
Overweight full-mouth disinfection
Arm Type
Experimental
Arm Description
Overweight (body mass index 25.0 - 29.9 kg/m2) individuals with chronic periodontitis Full-mouth manual scaling and root planing within 24 hours tongue cleaning with chlorhexidine gel 1% for 1 minute tonsils disinfection with chlorhexidine spray 0.2% rinsing with 15mL of 0.2% chlorhexidine solution for 30 seconds before and after dental scaling subgingival irrigation of all periodontal pockets with with 1% chlorhexidine solution daily rinsing with 0.2% chlorhexidine solution (15mL/30 seconds/2 times a day
Arm Title
Obesity I full-mouth disinfection
Arm Type
Experimental
Arm Description
Obesity I (body mass index 30.0 - 34.9 kg/m2) individuals with chronic periodontitis Full-mouth manual scaling and root planing within 24 hours tongue cleaning with chlorhexidine gel 1% for 1 minute tonsils disinfection with chlorhexidine spray 0.2% rinsing with 15mL of 0.2% chlorhexidine solution for 30 seconds before and after dental scaling subgingival irrigation of all periodontal pockets with with 1% chlorhexidine solution daily rinsing with 0.2% chlorhexidine solution (15mL/30 seconds/2 times a day
Arm Title
Obesity II full-mouth disinfection
Arm Type
Experimental
Arm Description
Obesity II (body mass index 35.0 - 39.9 kg/m2) individuals with chronic periodontitis Full-mouth manual scaling and root planing within 24 hours tongue cleaning with chlorhexidine gel 1% for 1 minute tonsils disinfection with chlorhexidine spray 0.2% rinsing with 15mL of 0.2% chlorhexidine solution for 30 seconds before and after dental scaling subgingival irrigation of all periodontal pockets with with 1% chlorhexidine solution daily rinsing with 0.2% chlorhexidine solution (15mL/30 seconds/2 times a day
Arm Title
Obesity III full-mouth disinfection
Arm Type
Experimental
Arm Description
Obesity III (body mass index ≥ 40.0 kg/m2) individuals with chronic periodontitis Full-mouth manual scaling and root planing within 24 hours tongue cleaning with chlorhexidine gel 1% for 1 minute tonsils disinfection with chlorhexidine spray 0.2% rinsing with 15mL of 0.2% chlorhexidine solution for 30 seconds before and after dental scaling subgingival irrigation of all periodontal pockets with with 1% chlorhexidine solution daily rinsing with 0.2% chlorhexidine solution (15mL/30 seconds/2 times a day
Intervention Type
Combination Product
Intervention Name(s)
One-stage full-mouth disinfection with chlorhexidine
Intervention Description
Mechanical procedures, composed of full-mouth dental scaling and root planning and dental prophylaxis, will be completed within 24 hours (2 appointments in 2 consecutive mornings or afternoons). Chlorhexidine will be used as the antimicrobial agent in different concentrations (0.2%, 1% and 2%) and vehicles (solution, gel). Oral hygiene instructions will be given for all participants.
Primary Outcome Measure Information:
Title
Periodontal clinical efficacy
Description
Improvements in periodontal pocket depth (mm) overtime and comparisons among groups at 6 months after treatment
Time Frame
Changes in periodontal pocket depth measurements from baseline to 6 months
Title
Periodontal clinical efficacy
Description
Improvements in clinical attachment level (mm) overtime and comparisons among groups at 6 months after treatment
Time Frame
Changes in clinical attachment measurements from baseline to 6 months
Secondary Outcome Measure Information:
Title
Antimicrobial efficacy
Description
Reductions in total bacterial levels and levels of target bacterial species overtime and comparisons among groups at 6 months after treatment
Time Frame
Changes in total bacterial levels from baseline to 6 months
Title
Antimicrobial efficacy
Description
Reductions in Treponema denticola, Porphyromonas gingivalis, Tannerella forsythia, Aggregatibacter actinomycetemcomitans levels overtime and comparisons among groups at 6 months after treatment
Time Frame
Changes in bacterial levels from baseline to 6 months
Title
Oral safety and tolerability
Description
Maintenance of salivary nitrite levels overtime and comparisons among groups at 6 months after treatment
Time Frame
Changes in salivary nitrite levels from baseline to 6 months
Title
Impact on quality of life
Description
Improvements in Oral health and quality of life - United Kingdom questionnaire scores overtime and comparisons among groups at 6 months after treatment
Time Frame
Changes in scores (Likert scale ranging from 16 to 80 points) of Oral health and quality of life - United Kingdom questionnaire from baseline to 6 months
Title
Impact on quality of life
Description
Improvements in Oral impacts on daily performance questionnaire scores overtime and comparisons among groups at 6 months after treatment
Time Frame
Changes in scores (Likert scale ranging from 0 to 56 points) of Oral impacts on daily performance questionnaire from baseline to 6 months
Other Pre-specified Outcome Measures:
Title
Systemic effects
Description
Glycemic blood levels.
Time Frame
Changes in in glycemic levels from baseline to 6 months.
Title
Systemic effects
Description
Blood levels of high density lipoprotein-cholesterol, low density lipoprotein -cholesterol, very low density lipoprotein - fractions levels parameters.
Time Frame
Changes in blood levels of high density lipoprotein-cholesterol, low density lipoprotein -cholesterol and very low density lipoprotein - fractions from baseline to 6 months.
Title
Systemic effects
Description
Blood counts of white cells, red cells and platelets.
Time Frame
Changes in blood counts of white cells, red cells and platelets from baseline to 6 months.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Moderate to advanced generalized chronic periodontitis Body mass index: > 18.5 kg/m2 Minimum of 12 natural teeth Smokers, non-smokers or former-smokers Exclusion Criteria: Systemic diseases (diabetes, renal diseases, rheumatic diseases, osteoporosis and cardiovascular diseases) Pregnant and lactating women HIV/ AIDS periodontal treatment in the last year (before baseline appointment) Medication: Immunosuppressive drugs, antibiotics in the past three months (before baseline appointment) ) orthodontic appliance
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jose R Cortelli, PhD
Organizational Affiliation
Associate professor
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Taubate
City
Taubate
State/Province
Sao Paulo
ZIP/Postal Code
12020330
Country
Brazil

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
IPD will not be shared

Learn more about this trial

Treatment of Periodontitis in Obese Individuals

We'll reach out to this number within 24 hrs